A Study of Fluvestrant Combined With Oral Vinorelbine in Hormone Receptor-positive Advanced Breast Cancer
Clinical trial NCT03939871 · UNKNOWN
Trial details
- NCT number
- NCT03939871
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-12
- Primary completion
- 2020-12-12
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.